« Previous
Next »
Titles
- Manufacturers may need additional guidance to ensure consistent calculations of average sales prices1
- Many Medicaid enrollees with opioid use disorder were treated with medication: however, disparities present concerns1
- Medicaid Managed Care: Rapid spending growth in state directed payments needs enhanced oversight and transparency : report to congressional addressees1
- Medicaid program integrity: Opportunities exist for CMS to strengthen use of state auditor findings and collaboration : report to congressional requesters1
- Medicare Part B drug payments: impact of price substitutions based on 2020 average sales prices1
- Medicare Part B drug payments: impact of price substitutions based on 2021 average sales prices1
- Medicare Part B spending on lab tests increased in 2021, driven by higher volume of COVID-19 tests, genetic tests, and chemistry tests1
- Medicare Part D: CMS should monitor effects of rebates on drug coverage and spending : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives1
- Medicare Part D: CMS should monitor effects of rebates on plan formularies and beneficiary spending : report to congressional requesters1
- Medicare cognitive assessments: utilization tripled between 2018 and 2022, but challenges remain : report to congressional committees1
- Medicare could save millions if it implements an expanded hospital transfer payment policy for early discharges to post acute care1
- Medicare telehealth services during the first year of the pandemic: program integrity risks1
- Medicare: Performance-based and geographic adjustments to physician payments : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives1
- Mental health services: State should collect ongoing feedback to ensure overseas employees’ needs are being met : report to congressional requesters1
- Michigan Medicaid Fraud Control Unit: 2021 review1
- Minnesota Medicaid Fraud Control Unit: 2022 Inspection1
- More than a thousand nursing homes reached infection rates of 75 percent or more in the first year of the COVID-19 pandemic: better protections are needed for future emergencies1